Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) share price
Aimei Health Technology Co., Ltd - Ordinary Share (NASDAQ:AFJK) last traded at $12.2, down 0.04% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.04B and a 52-week range of $6.75 to $130.37.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $12.2 |
| 1-day move | -0.04% |
| 52-week range | $6.75 - $130.37 |
| Market cap | $0.04B |
| From 52-week high | -90.60% |
| Volume vs average | 0.1x |
| Falling Shares risk score | 20/100 (MODERATE) |
| Country | United States |
Frequently asked questions
Why is Aimei Health Technology Co., Ltd - Ordinary Share falling today?
Aimei Health Technology Co., Ltd - Ordinary Share (NASDAQ:AFJK) is down 0.04% at its latest quote and trades 90.6% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Aimei Health Technology Co., Ltd - Ordinary Share share price today?
Aimei Health Technology Co., Ltd - Ordinary Share (NASDAQ:AFJK) last traded at $12.2, a -0.04% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Aimei Health Technology Co., Ltd - Ordinary Share?
Aimei Health Technology Co., Ltd - Ordinary Share's 52-week low is $6.75 and its 52-week high is $130.37; the shares trade 90.6% below the high.
What is the market cap of Aimei Health Technology Co., Ltd - Ordinary Share?
Aimei Health Technology Co., Ltd - Ordinary Share has a market capitalisation of about $0.04B at the latest price.
What are the risks of investing in Aimei Health Technology Co., Ltd - Ordinary Share?
Falling Shares Intelligence rates Aimei Health Technology Co., Ltd - Ordinary Share 20/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com